表紙
市場調査レポート

世界の核医学市場の見通し

Global Nuclear Medicine Outlook 2020

発行 RNCOS E-Services Pvt. Ltd. 商品コード 346850
出版日 ページ情報 英文 75 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
世界の核医学市場の見通し Global Nuclear Medicine Outlook 2020
出版日: 2015年12月07日 ページ情報: 英文 75 Pages
概要

世界の核医学市場は、今後数年間は力強い成長を維持すると見られています。市場は、2014年〜2020年のCAGRで、9.1%の成長が予測されています。

当レポートでは、世界の核医学市場について調査分析し、市場の現状と見通し、主要動向、促進要因と抑制要因、競合情勢と戦略的分析など、体系的な情報を提供しています。

第1章 アナリストの見解

第2章 調査手法

第3章 促進要因と課題

  • 促進要因
  • 課題

第4章 産業の概要

  • 核医学診断市場
  • 核医学治療市場
  • 核医学市場:地域別

第5章 最近の動向と発展

  • 核医学:オーダーメイド医療の成長を助ける
  • SPECTからPETシステムへ移行
  • ハイブリッドイメージングが市場成長を促進
  • モリブデン-99の不足を解消する取り組み
  • 市場の統合
  • 臨床試験数の増加

第6章 競合情勢

  • Advanced Accelerator Applications
  • Mallinckrodt
  • Lantheus Medical Imaging
  • IBA
  • Cardinal Health Inc.
  • Nordion Inc.
  • Siemens Healthcare
  • GE Healthcare

図表

目次

Nuclear Medicine is one of the most promising segments of the medical imaging industry; and is becoming increasingly popular for disease diagnosis and treatment due to safe, painless and cost effective procedures. The Nuclear Medicine has been witnessing a steady demand over the past few years, backed by the worldwide increase in the number of cancer and cardiovascular cases, increasing awareness about early disease detection, and an ever increasing ageing population.

According to our research report, “Global Nuclear Medicine Outlook 2020”, the Global Nuclear Medicine market is anticipated to sustain a robust growth in the coming years also, growing at a CAGR of 9.1% during the forecasted period (2014 to 2020). The market growth is expected mainly due to the application of Nuclear Medicine in the treatment of diseases, with many players investing heavily in the research and development of new therapeutic agents. The report provides information on the current scenario, market segmentation on the basis of application and geography, and future forecasts on all prominent segments of the industry till 2020.

Our segment-level analysis showed that Nuclear Medicine Diagnostics currently holds the biggest share of the total Nuclear Medicine market. However, the segment is expected to witness a slow growth in the future due to competition from conventional technologies like Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), high cost of Nuclear Medicine equipments and shortage of major diagnostic radiopharmaceuticals. Considering the growth rates, the therapeutics segment is expected to grow at a faster rate by 2020 with an increase in use of radiopharmaceuticals for targeted therapy.

Our report has been authored to evaluate the Global Nuclear Medicine market potentials, and identify future growth opportunities. It provides extensive research and analysis on major factors propelling the growth of the industry, challenges holding back the industry, and latest trends and developments in the market.

The report also provides an insight into the market consolidation during 2014 & 2015. With special emphasis on the competitive landscape and dominant players in the market, the research provides valuable information highlighting the opportunities in the Global Nuclear medicine market. The future analysis of the market scenario is likely to assist the intending clients to take informed and proactive business decisions in the evolving Nuclear Medicine market.

Table of Contents

1. Analyst View

2. Research Methodology

3. Drivers and Challenges

  • 3.1. Drivers
    • 3.1.1. Rising Incidences of Cancer and Cardiovascular Diseases
    • 3.1.2. Increasing Use of SPECT and PET Scans
    • 3.1.3. Rising Ageing Population
    • 3.1.4. Advances in Radiotracers
  • 3.2. Challenges
    • 3.2.1. Shut Down of Nuclear Reactors
    • 3.2.2. Short Half-life of Radiopharmaceuticals
    • 3.2.3. Production and Quality Control Challenges
    • 3.2.4. Reimbursement Issues

4. Industry Overview

  • 4.1. Nuclear Medicine Diagnostics Market
    • 4.1.1. Diagnostic Radiopharmaceuticals Market
    • 4.1.2. Nuclear Medicine Equipments Market
  • 4.2. Nuclear Medicine Therapeutics Market
  • 4.3. Nuclear Medicine Market by Geography

5. Recent Trends and Developments

  • 5.1. Nuclear Medicine: Aiding the Growth of Personalized Medicine
  • 5.2. Shift from SPECT to PET Systems
  • 5.3. Hybrid Imaging Propelling Market Growth
  • 5.4. Efforts Underway to Overcome Molybdenum-99 Shortage
  • 5.5. Consolidation in the Market
  • 5.6. Increasing Number of Clinical Trials

6. Competitive Landscape

  • 6.1. Advanced Accelerator Applications
  • 6.2. Mallinckrodt
  • 6.3. Lantheus Medical Imaging
  • 6.4. IBA
  • 6.5. Cardinal Health Inc.
  • 6.6. Nordion Inc.
  • 6.7. Siemens Healthcare
  • 6.8. GE Healthcare

List of Figures:

  • Figure 3-1: World - Number of Cancer Cases (Million), 2015 & 2035
  • Figure 3-2: World - Population Aged 60 and Above (Billion), 2014 & 2050
  • Figure 4-1: Global - Nuclear Medicine Market (Billion US$), 2014-2020
  • Figure 4-2: Nuclear Medicine Market Segmentation by Application (%), 2014
  • Figure 4-3: Nuclear Medicine Market Segmentation by Application (%), 2020
  • Figure 4-4: Nuclear Medicine Diagnostics Market Segmentation (%), 2014
  • Figure 4-5: Nuclear Medicine Diagnostics Market Segmentation (%), 2020
  • Figure 4-6: Global - Nuclear Medicine Diagnostics Market (Billion US$), 2014-2020
  • Figure 4-7: Medical Procedures Using Technetium - 99m (%), 2014
  • Figure 4-8: Global - Diagnostic Radiopharmaceuticals Market (Billion US$), 2014-2020
  • Figure 4-9: Global - Nuclear Medicine Equipments Market (Billion US$), 2014-2020
  • Figure 4-10: Global - Nuclear Medicine Therapeutics Market (Billion US$), 2014-2020
  • Figure 4-11: Global - Nuclear Medicine Market by Geographies (%), 2014

List of Tables:

  • Table 5-1: Recent M&A in the Global Nuclear Medicine Market (2014 - 2015)
  • Table 5-2: Major Products in the Pipeline
  • Table 6-1: Advanced Accelerator Applications - Revenue by Product Category (Million Euro), 2013 & 2014
  • Table 6-2: Advanced Accelerator Applications - Revenue by Countries (Million Euro), 2013 & 2014
  • Table 6-3: Advanced Accelerator Applications - Strengths & Weaknesses
  • Table 6-4: Mallinckrodt - Revenue by Business Segments (Million US$), 2013 & 2014
  • Table 6-5: Mallinckrodt - Revenue Breakup for Global Medical Imaging Segment (Million US$), 2013 & 2014
  • Table 6-6: Mallinckrodt - Strengths & Weaknesses
  • Table 6-7: Lantheus Medical Imaging - Revenue by Products (Million US$), 2013 & 2014
  • Table 6-8: Lantheus Medical Imaging - Strengths & Weaknesses
  • Table 6-9: IBA - Revenue by Business Segments (Million Euro), 2013 & 2014
  • Table 6-10: IBA - Strengths & Weaknesses
  • Table 6-11: Cardinal Health Inc. - Revenue by Business Segments (Billion US$), 2013 & 2014
  • Table 6-12: Cardinal Health Inc. - Strengths & Weaknesses
  • Table 6-13: Nordion Inc. - Strengths & Weaknesses
  • Table 6-14: Siemens Healthcare - Strengths and Weaknesses
  • Table 6-15: GE Healthcare - Strengths and Weaknesses
Back to Top